z-logo
Premium
Metabolism of glucose and glutamine in lymphocytes from graves' hyperthyroid patients: influence of methimazole treatment
Author(s) -
Werner M. C.,
Rosa L. F. B. P. Costa,
Romaldini J. H.,
Curi R.
Publication year - 1996
Publication title -
cell biochemistry and function
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.933
H-Index - 61
eISSN - 1099-0844
pISSN - 0263-6484
DOI - 10.1002/cbf.654
Subject(s) - glutaminase , glutamine , medicine , endocrinology , hormone , metabolism , carbohydrate metabolism , lymphocyte , immune system , hexokinase , biology , triiodothyronine , dehydrogenase , chemistry , enzyme , biochemistry , immunology , glycolysis , amino acid
Several studies have shown that thyroid hormones are able to influence selected immune responses such as cell mediated immunity, differentiation of B lymphocytes and the activity of NK cells. These hormones can also regulate the metabolism of glucose and glutamine in rat macrophages and their effects seem to occur mainly through the Krebs cycle. Alterations in the hexokinase, citrate synthase, glucose‐6‐phosphate dehydrogenase and glutaminase activities in lymphocytes from patients with Graves' disease, either untreated or on methimazole (MMI) therapy were investigated. Experiments were also done in vitro to determine the activities of these enzymes in normal lymphocytes cultured for 24 h in the presence of MMI, T 3 and T 4 using concentrations close to the physiological. Changes in the conversion of [U‐ 14 C]‐glucose and [U‐ 14 C]‐glutamine to 14 CO 2 as caused by the addition of MMI, T 3 or T 4 to the culture medium were also evaluated. The results indicate that high levels of thyroid hormones might stimulate the metabolism of glucose and glutamine for a short period of time but, if the stimulus is maintained, the utilization of glutamine by lymphocytes is then suppressed. Moreover, MMI does affect lymphocyte metabolism but the significance of this finding for its immunosuppressive effect remains to be examined.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here